Sunday July 07 2019 - Sunday Nation | Page 16 - 17
“I know the drug is very expensive but also very essential,” he said. According to the medical humanitarian organisation Médecins Sans Frontières (MSF), high prices and inaccessibility are major barriers to people accessing them. The MSF said that the problem has been caused by a monopoly by Gilead Sciences, a pharmaceutical firm that has failed to deliver on promises to make the drug available to people suffering from HIV.